The medical device development process is typically broken down into five distinct phases. Each one requires intense planning and bulletproof documentation to deliver products that exactly match customer needs and meet regulatory standards. Breaking down the device development process into phases helps medical device companies meet ISO 13485 and FDA requirements for...
DERBY BASED MEDICAL MANUFACTURER MAKES KEY HIRE TO HELP DRIVE COMMERCIAL GROWTH
Pennine Healthcare, one of the UK’s leading, employee owned, manufacturer and distributor, of single use, sterile Ward & Theatre Consumables and Custom Procedure Packs, has announced the appointment of a new Commercial Director as part of a re-shuffle of its current Sales Function. Jon Atkinson has joined the firm, who...
What is the role of digital in the new GP access recovery plan?
NHS England has published the new GP access recovery plan, with a focus to develop a sustainable general practice, improve digital access and tools, support citizen remote care, build capacity and expand supporting services such as community pharmacies. The blueprint “sets out actions to improve access to care, better support...
New blood brain barrier model created for the study of neurodegenerative disease
Specialist preclinical contract research organisation (CRO) Cellomatics Biosciences has launched a new in vitro model of the blood brain barrier (BBB) for research into neurodegenerative diseases. Developed and prepared in-house, INNOBEX™ is an in vitro model comprised of three primary cell types: endothelial cells (HBMVEC), pericytes and astrocytes. The model...
DHSC announces funding for primary care tech and care navigators
The Department of Health and Social Care has announced £240 million to support tech enhancements in primary care and funding for 6,500 care navigator training places. Ahead of the publication of the GP recovery plan, the announcement follows the direction recently noted around improving access, introducing cloud telephony and mandating...
Launch of Oncology Accelerator
Innovate UK’s Cancer Therapeutics programme has launched an Oncology Accelerator to support the development of early-stage health and life science innovation in the UK. Innovate UK is launching an Oncology Accelerator as part of its Cancer Therapeutics programme which aims to unleash business-led innovation from the UK’s vibrant research base....
Directors’ and Officers’ Insurance: A GUIDE FOR LIFE SCIENCES COMPANIES
Why D&O insurance for life sciences? Directors of life sciences businesses carry a huge weight of responsibility, and yet many companies, especially in the start-up phase, may not recognise the true value of a directors’ and officers’ policy. In a fast-moving, complex, and highly-regulated industry such as life sciences, it’s...
Shakespeare Martineau unveils new heads of East Midlands office hubs
As part of its accelerated growth strategy, full-service law firm Shakespeare Martineau has announced new heads of its East Midlands office hubs in Nottingham and Leicester. Corporate partner Lisa Botterill and residential development partner Louise Ingram will share the role of office head in Leicester, taking the helm following a...
2023 SEHTA Review: AgeTech UK Market Report
SEHTA is pleased to announce the release of our 2023 AgeTech UK Market Report. The UK Social Care market is a very segmented market that contains several different key players. The AgeTech UK Market Report provides an overview of the UK Social Care market with a focus on the implementation...
Cellomatics Biosciences – A warm welcome to Filipe and Emma
Cellomatics Biosciences welcomes two newcomers to the company this month. The appointments of Filipe Hanson and Emma Barker as Bio-Assay Scientists boosts the numbers at the growing Nottingham-based Contract Research Organisation. Filipe, 28, is from Lisbon, Portugal. He moved to the UK after completing his undergrad course in Biology to do his masters in...
